At last week’s #Advances in Oncology event by @OncBrothers at #GU25, I had the pleasure of engaging with panelists on the latest updates in #ProstateCancer cancer and connecting with the inspirational @Oncbrothers!Thanks for organizing such impactful events! @SignifyMD @SylvesterCancer @HemOncMiami

Had a great discussion with @VJOncology at #GU25, diving into our work on #HRR mutations and the evolving genomic landscape in #mCRPC. Also shared insights from our recent review on #LiquidBiopsy in #RCC. Exciting times for precision oncology! @SylvesterCancer

While the data for #LiquidBiopsy is evolving, our recent review explores its growing role in #RenalCellCarcinoma. @DrRanaMcKay @alantanmd @NourAbdalllah @SylvesterCancer @HemOncMiami @kidneycan @KidneyCancerJ @KidneyCancer pubmed.ncbi.nlm.nih.gov/39886007/

Great experience presenting our study ASCO #GU25 on the evolving #HRR mutational landscape in #metastatic #prostatecancer using the @guardant database. We uncovered de novo alterations post-taxane, PARPi, & ARSi. @DrRanaMcKay @SylvesterCancer